KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Progyny (PGNY) EBIT (2018 - 2025)

Historic EBIT for Progyny (PGNY) over the last 8 years, with Q3 2025 value amounting to $21.5 million.

  • Progyny's EBIT rose 7279.66% to $21.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $85.8 million, marking a year-over-year increase of 3112.05%. This contributed to the annual value of $67.5 million for FY2024, which is 847.65% up from last year.
  • Progyny's EBIT amounted to $21.5 million in Q3 2025, which was up 7279.66% from $24.4 million recorded in Q2 2025.
  • Over the past 5 years, Progyny's EBIT peaked at $24.4 million during Q2 2025, and registered a low of -$188000.0 during Q4 2021.
  • In the last 5 years, Progyny's EBIT had a median value of $13.8 million in 2023 and averaged $13.4 million.
  • In the last 5 years, Progyny's EBIT crashed by 11619.29% in 2021 and then soared by 2598103.45% in 2023.
  • Quarter analysis of 5 years shows Progyny's EBIT stood at -$188000.0 in 2021, then skyrocketed by 1858.51% to $3.3 million in 2022, then soared by 317.42% to $13.8 million in 2023, then grew by 14.4% to $15.8 million in 2024, then soared by 36.36% to $21.5 million in 2025.
  • Its last three reported values are $21.5 million in Q3 2025, $24.4 million for Q2 2025, and $24.2 million during Q1 2025.